ESC CONGRESS 2019

31 August - 04 September 2019, Paris - France

Session Details

Insight into atrial physiology and pathology Sun 01 Sep 10:05 - 10:55 Basic Science - Cardiac Diseases: Arrhythmias Moderated Posters, Abstract-based Programme Moderated ePoster 3 - Poster Area Chairpersons: Natasja DE GROOT (Rotterdam, Netherlands (The)), Dobromir DOBREV (Essen, Germany) Learning Objectives: Moderated Posters are on display from 08:30 to 11:30 on the plasma screen of the topic related Moderated Poster station. During the moderated poster session (10:05-10:55), from a large plasma screen, Presenters will summarise their research within 3 minutes and then address questions from the Chairpersons and Audience. Other resources List of Presentations Loading... Time   FP Nr   Title   Speakers   Related documents 10:05 P1229 Massive expansion of native human atrial cardiomyocytes through immortogenetics: generation of the hiAM cell lines Niels HARLAAR (Leiden, Netherlands (The)) 10:05 P1230 Impact of regulated junctophilin-2 clustering at axial tubule junctions on atrial excitation-contraction coupling and therapeutic implications Soeren BRANDENBURG (Goettingen, Germany) 10:05 P1231 Loss of function in cytoskeletal genes associates with early onset atrial fibrillation Oliver Bundgaard VAD (Copenhagen, Denmark) 10:05 P1232 A subpopulation of epicardium-derived cells are preprogrammed towards fibroblast differentiation in the atrial myocardium Nadine SUFFEE (Paris, France) 10:05 P1233 Differential effects of five risk variants for atrial fibrillation at the 4q25 region on L-type calcium current and transient inward currents in human atrial myocytes Carmen TARIFA (Barcelona, Spain) 10:05 P1234 Weight fluctuation demonstrates residual atrial arrhythmogenic substrate despite final weight loss in a chronic sheep model: implications for epicardial fat and fibrofatty infiltrates Thomas Adam AGBAEDENG (Adelaide, Australia) 10:05 P1235 Acetylcholine-activated inward-rectifier potassium currents in atrial cardiomyocytes derived from induced pluripotent stem cells and atrial engineered heart muscle preparations Robin SPRINGER (Goettingen, Germany)